Summary
0.22 -0.01(-5.00%)10/04/2024
Shineco Inc (SISI)
Shineco Inc (SISI)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -5.00 | -1.86 | -10.19 | -25.96 | -78.84 | -87.10 | 0.00 | -99.45 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 0.22 | |
| Open | 0.22 | |
| High | 0.23 | |
| Low | 0.21 | |
| Volume | 1,528,416 | |
| Change | -0.01 | |
| Change % | -5.00 | |
| Avg Volume (20 Days) | 234,262 | |
| Volume/Avg Volume (20 Days) Ratio | 6.52 | |
| 52 Week Range | 0.10 - 3.50 | |
| Price vs 52 Week High | -93.65% | |
| Price vs 52 Week Low | 117.19% | |
| Range | 0.00 | |
| Gap Up/Down | 0.00 | |
Fundamentals | ||
| Market Capitalization (Mln) | 2 | |
| EBIDTA | 0 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 0.00 | |
| Book Value | 4.1820 | |
| Earnings Per Share | -7.8020 | |
| EPS Estimate Current Quarter | 0.0000 | |
| EPS Estimate Next Quarter | 0.0000 | |
| EPS Estimate Current Year | 0.0000 | |
| EPS Estimate Next Year | 0.0000 | |
| Diluted EPS (TTM) | -7.8020 | |
| Revenues | ||
| Profit Marging | 0.0000 | |
| Operating Marging (TTM) | -9.5020 | |
| Return on asset (TTM) | -0.2073 | |
| Return on equity (TTM) | -0.5991 | |
| Revenue TTM | 2,643,485 | |
| Revenue per share TTM | 0.4620 | |
| Quarterly Revenue Growth (YOY) | -0.3750 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | -287,694 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.7741 | |
| Revenue Enterprise Value | 25.2388 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 9,087,280 | |
| Shares Float | 7,248,739 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 21.41 | |
| Institutions (%) | 1.84 | |
08/09 09:00 EST - prnewswire.com
Future FinTech Announces the Appointment of Hu Li as the New CEO
NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Future Fintech Group Inc. (NASDAQ: FTFT), (hereinafter referred to as "Future FinTech", "FTFT" or the "Company"), a comprehensive financial and digital technology service provider, today announced that its Board of Directors (the "Board") approved the appointment of Mr. Hu Li as Chief Executive Officer ("CEO"), President and a member of the Board of the Company, effective August 5, 2024.
Future FinTech Announces the Appointment of Hu Li as the New CEO
NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Future Fintech Group Inc. (NASDAQ: FTFT), (hereinafter referred to as "Future FinTech", "FTFT" or the "Company"), a comprehensive financial and digital technology service provider, today announced that its Board of Directors (the "Board") approved the appointment of Mr. Hu Li as Chief Executive Officer ("CEO"), President and a member of the Board of the Company, effective August 5, 2024.
07/15 16:05 EST - globenewswire.com
Shineco Announces Closing of $2 Million Underwritten Public Offering
Beijing, July 15, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the closing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 280,374 shares of common stock at the public offering price per share, less the underwriting discounts to cover over-allotments, if any.
Shineco Announces Closing of $2 Million Underwritten Public Offering
Beijing, July 15, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the closing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 280,374 shares of common stock at the public offering price per share, less the underwriting discounts to cover over-allotments, if any.
07/12 08:27 EST - investorplace.com
Why Is Shineco (SISI) Stock Down 54% Today?
Shineco (NASDAQ: SISI ) stock is falling hard on Friday after the agricultural produce company announced the pricing of a public offering for its shares. This public offering has Shineco selling 1,869,160 shares of SISI stock for $1.07 each.
Why Is Shineco (SISI) Stock Down 54% Today?
Shineco (NASDAQ: SISI ) stock is falling hard on Friday after the agricultural produce company announced the pricing of a public offering for its shares. This public offering has Shineco selling 1,869,160 shares of SISI stock for $1.07 each.
07/12 08:00 EST - globenewswire.com
Shineco Announces Pricing of $2 Million Underwritten Public Offering
Beijing, July 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the pricing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 280,374 shares of common stock at the public offering price per share, less the underwriting discounts to cover over-allotments, if any. The offering is expected to close on July 15, 2024, subject to satisfaction of customary closing conditions.
Shineco Announces Pricing of $2 Million Underwritten Public Offering
Beijing, July 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the pricing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 280,374 shares of common stock at the public offering price per share, less the underwriting discounts to cover over-allotments, if any. The offering is expected to close on July 15, 2024, subject to satisfaction of customary closing conditions.
07/11 16:45 EST - globenewswire.com
Shineco Announces Proposed Underwritten Public Offering
Beijing, July 11, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced it has commenced an underwritten public offering of shares of its common stock and pre-funded warrants to purchase its shares of common stock. All of the shares of common stock and pre-funded warrants and the shares of common stock underlying the pre-funded warrants are being offered by the Company. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Shineco Announces Proposed Underwritten Public Offering
Beijing, July 11, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced it has commenced an underwritten public offering of shares of its common stock and pre-funded warrants to purchase its shares of common stock. All of the shares of common stock and pre-funded warrants and the shares of common stock underlying the pre-funded warrants are being offered by the Company. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
06/27 09:00 EST - globenewswire.com
Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement
BEIJING, June 27, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today that on June 5, 2024, the Company received a formal notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). The notice indicated that as a result of the closing bid price of the Company's common stock having been at least $1.00 per share for the period of 10 consecutive business days, from May 20, 2024 through June 4, 2024, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and advised that this matter is now closed.
Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement
BEIJING, June 27, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today that on June 5, 2024, the Company received a formal notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). The notice indicated that as a result of the closing bid price of the Company's common stock having been at least $1.00 per share for the period of 10 consecutive business days, from May 20, 2024 through June 4, 2024, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and advised that this matter is now closed.
06/24 09:00 EST - globenewswire.com
Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of $7.0 Million
BEIJING, June 24, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that on June 20, 2024, the Company entered into a Securities Purchase Agreement (the “SPA”) with certain non-U.S. investors (each individually, a “Purchaser,” and collectively, the “Purchasers”). Pursuant to the SPA, the Company will issue up to 1,400,000 shares of its common stock (the “Shares”) to the Purchasers in a private placement financing transaction (the “Offering”) at an offering price of $5.00 per share. The gross proceeds of the Offering are expected to be approximately $7,000,000, before the deduction of customary expenses. The Purchasers are a former related party of the Company, who agreed to purchase 1,000,000 shares of common stock, a management member of the Company, who agreed to purchase 200,000 shares of common stock, and an individual investor who agreed to purchase 200,000 shares of common stock. The Offering is expected to close, and the Shares are expected to be issued, on or about July 31, 2024.
Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of $7.0 Million
BEIJING, June 24, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that on June 20, 2024, the Company entered into a Securities Purchase Agreement (the “SPA”) with certain non-U.S. investors (each individually, a “Purchaser,” and collectively, the “Purchasers”). Pursuant to the SPA, the Company will issue up to 1,400,000 shares of its common stock (the “Shares”) to the Purchasers in a private placement financing transaction (the “Offering”) at an offering price of $5.00 per share. The gross proceeds of the Offering are expected to be approximately $7,000,000, before the deduction of customary expenses. The Purchasers are a former related party of the Company, who agreed to purchase 1,000,000 shares of common stock, a management member of the Company, who agreed to purchase 200,000 shares of common stock, and an individual investor who agreed to purchase 200,000 shares of common stock. The Offering is expected to close, and the Shares are expected to be issued, on or about July 31, 2024.
06/20 09:00 EST - globenewswire.com
Shineco Enters into a Letter of Intent with Meitong Technology to Address China's Aging Population
BEIJING, June 20, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDA: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that on June 18, 2024, it entered into an Investment Letter of Intent (the “Investment LOI”) with Beijing Oriental Meitong Technology Co., Ltd. (“Meitong Technology”) whereby Shineco intends to invest $20 million in Meitong Technology in exchange for 80% of Meitong Technology's shares. The Company believes that the acquisition of equity in Meitong Technology will add to the Company's core competencies and result in operating synergies that will enhance the Company's value proposition.
Shineco Enters into a Letter of Intent with Meitong Technology to Address China's Aging Population
BEIJING, June 20, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDA: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that on June 18, 2024, it entered into an Investment Letter of Intent (the “Investment LOI”) with Beijing Oriental Meitong Technology Co., Ltd. (“Meitong Technology”) whereby Shineco intends to invest $20 million in Meitong Technology in exchange for 80% of Meitong Technology's shares. The Company believes that the acquisition of equity in Meitong Technology will add to the Company's core competencies and result in operating synergies that will enhance the Company's value proposition.
06/17 09:00 EST - globenewswire.com
Shineco Enters into an Agreement with Turing Video to Jointly Develop Intelligent Health Care Products
Beijing, June 17, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that on June 14, 2024, its 51% owned subsidiary, Shangkang Life Science and Technology (Jiangsu) Co., Ltd. (“Shangkang Life Science”) entered into a Strategic Cooperation Framework Agreement (“the Agreement”) with Turing Video (Shenzhen) Co., Ltd (“Turing Video”) to jointly develop a series of smart medical products and introduce their biotechnology and other innovative health solutions to the healthcare market.
Shineco Enters into an Agreement with Turing Video to Jointly Develop Intelligent Health Care Products
Beijing, June 17, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that on June 14, 2024, its 51% owned subsidiary, Shangkang Life Science and Technology (Jiangsu) Co., Ltd. (“Shangkang Life Science”) entered into a Strategic Cooperation Framework Agreement (“the Agreement”) with Turing Video (Shenzhen) Co., Ltd (“Turing Video”) to jointly develop a series of smart medical products and introduce their biotechnology and other innovative health solutions to the healthcare market.
05/20 13:28 EST - http://feeds.benzinga.com
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Virios Therapeutics, Inc. VIRI fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share. Virios Therapeutics shares dipped 47.6% to $0.1850 on Monday. Here are some other stocks moving in today’s mid-day session. MultiMetaVerse Holdings Limited MMV shares jumped 224% to $2.01. MultiMetaVerse Holdings signed a non-binding term sheet to acquire 100% of Bowong Technology (Shenzhen) Co., Ltd. and its subsidiaries. GT Biopharma, Inc. GTBP rose 146% to $7.64. GT Biopharma, last week, posted a narrower-than-expected quarterly loss. Tantech Holdings Ltd TANH jumped 89.8% to $1.2501. Faraday Future Intelligent Electric Inc. FFIE shares gained 62.1% to $1.6701. Faraday Future Intelligent Electric is scheduled to report its fourth quarter and full year 2023 results after the closing bell on Tuesday, May 28. CN Energy Group. Inc. CNEY surged 58% to $1.0501. Scorpius Holdings, Inc. SCPX gained 57.8% to $0.1635. Scorpius, last week, announced closing of public offering. NKGen Biotech, Inc. NKGN rose 46% to $1.6250 after the company’s SNK01 NK Cell Therapy was cleared to begin a Phase 2 trial in Alzheimer’s disease. Bruush Oral Care Inc. BRSH jumped 41% to $0.1658. Rekor Systems, Inc. REKR gained 36% to $1.80 after the company announced a partnership with MS2. MIRA Pharmaceuticals, Inc. MIRA gained 34.3% to $0.8866 after the company said it has advanced new preclinical studies using Ketamir-2 towards clinical development. Scilex Holding Company SCLX gained 34% to $1.21. Hims & Hers Health, Inc. HIMS rose 30.5% to $19.01 after the company announced the addition of GLP-1 injections to its weight loss portfolio. BYND Cannasoft Enterprises Inc. BCAN surged 29.5% to $1.4250. Cheetah Mobile Inc. CMCM gained 24.3% to $5.70. Concord Medical Services Holdings Limited CCM jumped 23% to $0.6188. Wix.com Ltd. WIX rose 21.6% to $164.94 as the company posted upbeat results for its first quarter and raised its 2024 forecast on Monday. Sintx Technologies, Inc. SINT shares rose 21.1% to $0.1029 after dipping over 39% on Friday. Sutro Biopharma, Inc. STRO climbed 17.6% to $4.7150. PTC Therapeutics, Inc. PTCT jumped 17.2% to $38.78 after the company announced the European Commission has returned the Translarna opinion to the CHMP for re-evaluation. Cue Health Inc. HLTH gained 17.1% to $0.1128 after dipping around 18% on Friday. Cue Health, last week, announced that it voluntarily and temporarily paused sales and distribution of its EUA COVID-19 Test Cartridge. NextDecade Corporation NEXT climbed 16% to $8.10 after ADNOC announced it secured an equity position and LNG offtake agreement in NextDecade’s Rio Grande LNG project. NuScale Power Corporation SMR rose 15.5% to $7.29. VinFast Auto Ltd. VFS gained 15% to $5.61. Crown ElectroKinetics Corp. CRKN shares rose 14.8% to $0.1964 after falling around 29% on Friday. Tellurian Inc. TELL gained 14% to $0.5870. Shineco, Inc. SISI shares climbed 10.2% to $1.09 after jumping 19% on Friday. Shineco recently announced that its subsidiaries Fuzhou Medashan Biotechnology and Kaifeng Yixi Biotechnology invented a new natural active water-soluble product. Independent Bank Group, Inc. IBTX gained 8.5% to $47.69 after SouthState announced it will acquire the company. Doximity, Inc. DOCS surged 5.1% to $29.46. Akoustis Technologies, Inc. AKTS fell 53.8% to $0.1647 after Qorvo won a jury verdict against the company in a trade secret misappropriation and patent infringement case. Cheetah Net Supply Chain Service Inc. CTNT declined 48% to $5.61. FLJ Group Limited FLJ shares fell 44.5% to $0.86 after surging 224% on Friday. Jaguar Health, Inc JAGX fell 39.8% to $0.1557 after the company announced a 1-for-60 reverse stock split. Fangdd Network Group Ltd. DUO declined 38% to $1.04. Jeffs’ Brands Ltd JFBR shares declined 35.8% to $0.4189 after jumping 109% on Friday. DermTech, Inc. DMTK fell 33.8% to $0.3302. CervoMed Inc. CRVO declined 25.3% to $17.99. CervoMed named William Elder as Chief Financial Officer, effective June 1. Barnes & Noble Education, Inc. BNED dipped 22.6% to $0.3482. Akanda Corp. AKAN shares fell 22.3% to $0.1339 following a 30% surge on Friday. iPower Inc. IPW shares fell 20.8% to $2.29 after jumping 98% on Friday. iPower, last week, reported better-than-expected third-quarter financial results. Nature’s Miracle Holding Inc. NMHI declined 19.9% to $0.5396. Nature’s Miracle mutually agreed to terminate plan to merge with Agrify Corp. Li Auto Inc. LI fell 12.6% to $21.74 after the company reported worse-than-expected first-quarter results and issued second-quarter guidance. GameStop Corp. GME declined 10% to $19.99. Oklo Inc. OKLO fell 8.6% to $8.23. IGM Biosciences, Inc. IGMS declined 8.2% to $8.46. Cemtrex, Inc. CETX shares fell 7.6% to $0.45 after climbing 49% on Friday. Cemtrex, last week, posted a wider quarterly loss. The Beauty Health Company SKIN declined 5.8% to $2.58. Inovio Pharmaceuticals, Inc. INO fell 5.6% to $11.33. ATRenew Inc. RERE shares fell 4.3% to $2.71 after reporting weak quarterly earnings. Now Read This: How To Earn $500 A Month From Lowe’s Stock Ahead Of Q1 Earnings Report © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Virios Therapeutics, Inc. VIRI fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share. Virios Therapeutics shares dipped 47.6% to $0.1850 on Monday. Here are some other stocks moving in today’s mid-day session. MultiMetaVerse Holdings Limited MMV shares jumped 224% to $2.01. MultiMetaVerse Holdings signed a non-binding term sheet to acquire 100% of Bowong Technology (Shenzhen) Co., Ltd. and its subsidiaries. GT Biopharma, Inc. GTBP rose 146% to $7.64. GT Biopharma, last week, posted a narrower-than-expected quarterly loss. Tantech Holdings Ltd TANH jumped 89.8% to $1.2501. Faraday Future Intelligent Electric Inc. FFIE shares gained 62.1% to $1.6701. Faraday Future Intelligent Electric is scheduled to report its fourth quarter and full year 2023 results after the closing bell on Tuesday, May 28. CN Energy Group. Inc. CNEY surged 58% to $1.0501. Scorpius Holdings, Inc. SCPX gained 57.8% to $0.1635. Scorpius, last week, announced closing of public offering. NKGen Biotech, Inc. NKGN rose 46% to $1.6250 after the company’s SNK01 NK Cell Therapy was cleared to begin a Phase 2 trial in Alzheimer’s disease. Bruush Oral Care Inc. BRSH jumped 41% to $0.1658. Rekor Systems, Inc. REKR gained 36% to $1.80 after the company announced a partnership with MS2. MIRA Pharmaceuticals, Inc. MIRA gained 34.3% to $0.8866 after the company said it has advanced new preclinical studies using Ketamir-2 towards clinical development. Scilex Holding Company SCLX gained 34% to $1.21. Hims & Hers Health, Inc. HIMS rose 30.5% to $19.01 after the company announced the addition of GLP-1 injections to its weight loss portfolio. BYND Cannasoft Enterprises Inc. BCAN surged 29.5% to $1.4250. Cheetah Mobile Inc. CMCM gained 24.3% to $5.70. Concord Medical Services Holdings Limited CCM jumped 23% to $0.6188. Wix.com Ltd. WIX rose 21.6% to $164.94 as the company posted upbeat results for its first quarter and raised its 2024 forecast on Monday. Sintx Technologies, Inc. SINT shares rose 21.1% to $0.1029 after dipping over 39% on Friday. Sutro Biopharma, Inc. STRO climbed 17.6% to $4.7150. PTC Therapeutics, Inc. PTCT jumped 17.2% to $38.78 after the company announced the European Commission has returned the Translarna opinion to the CHMP for re-evaluation. Cue Health Inc. HLTH gained 17.1% to $0.1128 after dipping around 18% on Friday. Cue Health, last week, announced that it voluntarily and temporarily paused sales and distribution of its EUA COVID-19 Test Cartridge. NextDecade Corporation NEXT climbed 16% to $8.10 after ADNOC announced it secured an equity position and LNG offtake agreement in NextDecade’s Rio Grande LNG project. NuScale Power Corporation SMR rose 15.5% to $7.29. VinFast Auto Ltd. VFS gained 15% to $5.61. Crown ElectroKinetics Corp. CRKN shares rose 14.8% to $0.1964 after falling around 29% on Friday. Tellurian Inc. TELL gained 14% to $0.5870. Shineco, Inc. SISI shares climbed 10.2% to $1.09 after jumping 19% on Friday. Shineco recently announced that its subsidiaries Fuzhou Medashan Biotechnology and Kaifeng Yixi Biotechnology invented a new natural active water-soluble product. Independent Bank Group, Inc. IBTX gained 8.5% to $47.69 after SouthState announced it will acquire the company. Doximity, Inc. DOCS surged 5.1% to $29.46. Akoustis Technologies, Inc. AKTS fell 53.8% to $0.1647 after Qorvo won a jury verdict against the company in a trade secret misappropriation and patent infringement case. Cheetah Net Supply Chain Service Inc. CTNT declined 48% to $5.61. FLJ Group Limited FLJ shares fell 44.5% to $0.86 after surging 224% on Friday. Jaguar Health, Inc JAGX fell 39.8% to $0.1557 after the company announced a 1-for-60 reverse stock split. Fangdd Network Group Ltd. DUO declined 38% to $1.04. Jeffs’ Brands Ltd JFBR shares declined 35.8% to $0.4189 after jumping 109% on Friday. DermTech, Inc. DMTK fell 33.8% to $0.3302. CervoMed Inc. CRVO declined 25.3% to $17.99. CervoMed named William Elder as Chief Financial Officer, effective June 1. Barnes & Noble Education, Inc. BNED dipped 22.6% to $0.3482. Akanda Corp. AKAN shares fell 22.3% to $0.1339 following a 30% surge on Friday. iPower Inc. IPW shares fell 20.8% to $2.29 after jumping 98% on Friday. iPower, last week, reported better-than-expected third-quarter financial results. Nature’s Miracle Holding Inc. NMHI declined 19.9% to $0.5396. Nature’s Miracle mutually agreed to terminate plan to merge with Agrify Corp. Li Auto Inc. LI fell 12.6% to $21.74 after the company reported worse-than-expected first-quarter results and issued second-quarter guidance. GameStop Corp. GME declined 10% to $19.99. Oklo Inc. OKLO fell 8.6% to $8.23. IGM Biosciences, Inc. IGMS declined 8.2% to $8.46. Cemtrex, Inc. CETX shares fell 7.6% to $0.45 after climbing 49% on Friday. Cemtrex, last week, posted a wider quarterly loss. The Beauty Health Company SKIN declined 5.8% to $2.58. Inovio Pharmaceuticals, Inc. INO fell 5.6% to $11.33. ATRenew Inc. RERE shares fell 4.3% to $2.71 after reporting weak quarterly earnings. Now Read This: How To Earn $500 A Month From Lowe’s Stock Ahead Of Q1 Earnings Report © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
05/01 05:14 EST - prnewswire.com
Shineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care Industry
BEIJING , May 1, 2024 /PRNewswire/ -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that its subsidiaries Fuzhou Medashan Biotechnology Co., Ltd. and Kaifeng Yixi Biotechnology Co., Ltd.
Shineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care Industry
BEIJING , May 1, 2024 /PRNewswire/ -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that its subsidiaries Fuzhou Medashan Biotechnology Co., Ltd. and Kaifeng Yixi Biotechnology Co., Ltd.
02/14 07:00 EST - globenewswire.com
Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
BEIJING, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that the Company's Board of Directors has approved a reverse stock split of its issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”), at a ratio of 1-for-10. The Company is effecting the reverse split to regain compliance with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).
Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
BEIJING, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that the Company's Board of Directors has approved a reverse stock split of its issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”), at a ratio of 1-for-10. The Company is effecting the reverse split to regain compliance with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).
11/17 09:00 EST - globenewswire.com
Shineco Announces the Appointment of Two New Executive Officers
BEIJING, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that its Board of Directors has appointed Ms. Xiaohui Wang and Mr. Chi Keung Yan as executive officers of the Company in key leadership roles.
Shineco Announces the Appointment of Two New Executive Officers
BEIJING, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that its Board of Directors has appointed Ms. Xiaohui Wang and Mr. Chi Keung Yan as executive officers of the Company in key leadership roles.
10/30 09:00 EST - globenewswire.com
Shineco Opens Healthy Food Restaurant with Focus on Advanced Nutrition
SISI Anticipates the Roll-Out of Additional Restaurants to Develop a Chain of Healthy Food Restaurants BEIJING, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today the grand opening of its first carry-out restaurant which will sell Shineco's new healthy and nutritious food brand, ‘Meida Nutritionary Restaurant”. Shineco's first carry-out restaurant is located on Baihuazhou Road, Cangshan, Fuzhou City, China.
Shineco Opens Healthy Food Restaurant with Focus on Advanced Nutrition
SISI Anticipates the Roll-Out of Additional Restaurants to Develop a Chain of Healthy Food Restaurants BEIJING, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today the grand opening of its first carry-out restaurant which will sell Shineco's new healthy and nutritious food brand, ‘Meida Nutritionary Restaurant”. Shineco's first carry-out restaurant is located on Baihuazhou Road, Cangshan, Fuzhou City, China.
10/04 09:00 EST - globenewswire.com
Shineco to Increase R&D to Explore New High-Tech Medical Product Applications
The Recent Acquisition of a Majority Stake in a Manufacturer of Antibacterial and Antiviral Fabrics Expected to Create Synergies for New Products
Shineco to Increase R&D to Explore New High-Tech Medical Product Applications
The Recent Acquisition of a Majority Stake in a Manufacturer of Antibacterial and Antiviral Fabrics Expected to Create Synergies for New Products
08/29 08:12 EST - investorplace.com
Why Is Shineco (SISI) Stock Up 40% Today?
Shineco (NASDAQ: SISI ) stock is on the rise Tuesday without any clear news from the company this morning. Instead, it looks like traders can point to increased activity as the reason for today's rally.
Why Is Shineco (SISI) Stock Up 40% Today?
Shineco (NASDAQ: SISI ) stock is on the rise Tuesday without any clear news from the company this morning. Instead, it looks like traders can point to increased activity as the reason for today's rally.
07/10 09:00 EST - globenewswire.com
Shineco Subsidiary Receives Marketing Approval from China's Regulatory Body for its Cardiac 5-Minute Test
Registration with the NMPA, China's Regulatory Equivalent to the FDA, is a Prerequisite to Marketing and Distribution
Shineco Subsidiary Receives Marketing Approval from China's Regulatory Body for its Cardiac 5-Minute Test
Registration with the NMPA, China's Regulatory Equivalent to the FDA, is a Prerequisite to Marketing and Distribution